Inactive Instrument

News Spectrum Pharmaceuticals, Inc.

Stocks

SPPI

US84763A1088

Biotechnology & Medical Research

All News

23-08-02	Spectrum Pharmaceuticals, Inc.(NasdaqCM:SPPI) dropped from S&P Global BMI Index	CI
23-08-02	Spectrum Pharmaceuticals, Inc.(NasdaqCM:SPPI) dropped from S&P TMI Index	CI
23-08-01	Spectrum Pharmaceuticals, Inc. Announces Cessation of Directors	CI
23-08-01	Spectrum Pharmaceuticals, Inc.(NasdaqCM:SPPI) dropped from NASDAQ Composite Index	CI
23-07-31	Assertio Holdings, Inc. Closes Spectrum Pharmaceuticals Transaction	AQ
23-07-27	Assertio Holdings, Inc. Announces Favorable Vote on Proposed Acquisition of Spectrum Pharmaceuticals	AQ
23-07-20	Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “FOR” Proposed Transaction with Assertio Holdings, Inc.	BU
23-06-30	SPECTRUM PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Spectrum Pharmaceuticals, Inc. - SPPI	BU
23-05-17	Spectrum Pharmaceuticals Regains Nasdaq Compliance	MT
23-05-17	Spectrum Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement	BU
23-05-15	Jefferies Downgrades Spectrum Pharmaceuticals to Hold From Buy, Cuts Price Target to $1.50 From $3.50	MT
23-05-09	Spectrum Pharma: Q1 Earnings Snapshot	AQ
23-05-09	Spectrum Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
23-05-09	Earnings Flash (SPPI) SPECTRUM PHARMACEUTICALS Reports Q1 Revenue $15.6M	MT
23-05-09	Spectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update	BU
23-05-08	B. Riley Lifts Spectrum Pharmaceuticals' Price Target to $1.14 From $1 on Heels of Announced Sale to Assertio Holdings, Keeps Neutral Rating	MT
23-05-01	SPECTRUM PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)	AQ
23-04-26	JMP Securities Downgrades Spectrum Pharmaceuticals to Market Perform From Market Outperform	MT
23-04-26	HC Wainwright Downgrades Spectrum Pharmaceuticals to Neutral From Buy	MT
23-04-26	JMP Securities Downgrades Spectrum Pharmaceuticals to Market Perform From Outperform	MT
23-04-25	SPECTRUM PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Spectrum Pharmaceuticals, Inc. - SPPI	BU
23-04-25	SPECTRUM PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
23-04-04	SPECTRUM PHARMACEUTICALS INC : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
23-04-04	Spectrum Pharmaceuticals : Current Corporate Presentation	PU
23-04-03	SPECTRUM PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)	AQ